Evidence map›Paper›PMID 35416931›Full record

ArticleThe Journal of cell biology2022

An unexpected role for PD-L1 in front-rear polarization and directional migration.

Miguel Sánchez-Álvarez, Miguel A Del Pozo

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Miguel Sánchez-ÁlvarezCell and Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Miguel A Del PozoCell and Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Spanish National Centre for Cardiovascular Research · ES

Funding

Asociación Española Contra el Cáncer PROYE20089DELPCentro Nacional de Investigaciones Cardiovasculares International Postdoctoral Programme COFUND Marie Skłodowska-Curie ActionsInstituto de Salud Carlos IIILa Caixa Health Research Programme HR20-00075La Marató TV3 201936-30-31Ministerio de Ciencia e InnovaciónMinisterio de Ciencia e Innovación CEX2020-001041-SPro CNIC FoundationSpanish Ministry of Science and Innovation RYC2020-029690-ITec4Bio 2021Y
6 · The paper itself

Abstract

Programmed cell death-ligand 1 (PD-L1)-mediated T cell inhibition through PD-1 is a key checkpoint frequently exploited by tumors to evade immunity. In this issue, Wang et al. (2022. J. Cell Biol.https://doi.org/10.1083/jcb.202108083) reveal an unexpected role for PD-L1 in promoting tumor cell front-rear polarity and directionally persistent cell migration, independently of PD-1.

Indexed as

B7-H1 AntigenNeoplasmsCell MovementHumansProgrammed Cell Death 1 ReceptorT-LymphocytesTumor EscapeB7-H1 AntigenProgrammed Cell Death 1 Receptor

Identifiers

PMID35416931
PMCPMC9011200
OpenAlexW4223647758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.